Semler Scientific Inc (SMLR) - Total Liabilities

Latest as of September 2025: $136.93 Million USD

Based on the latest financial reports, Semler Scientific Inc (SMLR) has total liabilities worth $136.93 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Semler Scientific Inc (SMLR) cash flow conversion to assess how effectively this company generates cash.

Semler Scientific Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Semler Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Semler Scientific Inc to evaluate the company's liquid asset resilience ratio.

Semler Scientific Inc Competitors by Total Liabilities

The table below lists competitors of Semler Scientific Inc ranked by their total liabilities.

Company Country Total Liabilities
Autolus Therapeutics plc
F:6A3A
Germany €396.50 Million
INPAQ Technology Co Ltd
TWO:6284
Taiwan NT$6.38 Billion
CMC Magnetics Corp
TW:2323
Taiwan NT$10.50 Billion
Lands’ End Inc
NASDAQ:LE
USA $621.65 Million
ON24 Inc
NYSE:ONTF
USA $88.91 Million
Dalmia Bharat Sugar and Industries Limited
NSE:DALMIASUG
India Rs10.09 Billion
Eugene Inv&Sec
KO:001200
Korea ₩9.14 Trillion

Liability Composition Analysis (2011–2024)

This chart breaks down Semler Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Semler Scientific Inc (SMLR) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.97 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.23 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Semler Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Semler Scientific Inc (2011–2024)

The table below shows the annual total liabilities of Semler Scientific Inc from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 $9.08 Million +44.78%
2023-12-31 $6.27 Million -10.65%
2022-12-31 $7.02 Million +36.92%
2021-12-31 $5.12 Million +5.76%
2020-12-31 $4.85 Million -7.06%
2019-12-31 $5.21 Million +48.00%
2018-12-31 $3.52 Million -48.35%
2017-12-31 $6.82 Million +13.85%
2016-12-31 $5.99 Million +44.33%
2015-12-31 $4.15 Million +2.14%
2014-12-31 $4.06 Million +101.29%
2013-12-31 $2.02 Million -60.03%
2012-12-31 $5.05 Million +341.91%
2011-12-31 $1.14 Million --

About Semler Scientific Inc

NASDAQ:SMLR USA Medical Devices
Market Cap
$5.38 Billion
Market Cap Rank
#14355 Global
#3244 in USA
Share Price
$355.43
Change (1 day)
+0.18%
52-Week Range
$15.21 - $355.43
All Time High
$355.43
About

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more